Tags

DHG

Pharmaceutical firms post great profits last year

Pharmaceutical firms post great profits last year

Rising demand is one of the reasons explaining many pharmaceutical companies'' favourable business results.
Pharmaceutical firms show mixed performance

Pharmaceutical firms show mixed performance

Six-month revenues of pharmaceutical firms paint a mixed picture of the industry in the first half.
Pharmaceutical enterprises enjoy good earnings in Q1

Pharmaceutical enterprises enjoy good earnings in Q1

Pharmaceutical stocks have attracted investors since the outbreak of the disease due to rising need for medical equipment and drugs.
VN healthcare market, a big draw for investors, foreign and local

VN healthcare market, a big draw for investors, foreign and local

Last year, VinaCapital’s flagship fund, Vietnam Opportunity Fund (VOF), invested US$25 million in a private hospital operator, Tam Tri Medical Joint Stock Company.
Pharmaceutical stocks benefit from disease spread

Pharmaceutical stocks benefit from disease spread

Pharmaceutical stocks are experiencing an upsurge as fears of coronavirus have boosted demand for healthcare products and services, lifting demand for shares.
Taisho takes control of Hau Giang Pharmaceutical

Taisho takes control of Hau Giang Pharmaceutical

Hau Giang Pharmaceutical Joint Stock Company (DHG) has become a subsidiary of Japan’s Taisho Pharmaceutical Co Ltd.
Taisho wants larger stake in DHG Pharmaceutical

Taisho wants larger stake in DHG Pharmaceutical

Japan’s Taisho Pharmaceutical Co Ltd has proposed increasing its ownership in DHG Pharmaceutical Joint Stock Company by 21.7 per cent.
Bitter pill to swallow for pharmaceutical investors

Bitter pill to swallow for pharmaceutical investors

Pharmaceutical stocks could be a bad bet this year, as the firms are set to report slower earnings growth for 2018.
Taisho attempts to purchase more DHG shares

Taisho attempts to purchase more DHG shares

Japan’s Taisho Pharmaceutical Co Ltd will continue attempting to purchase the Hau Giang Pharmaceutical JSC’s stakes after the Vietnamese company lifted the cap on foreign ownership to 100 per cent.
DHG sees profits rise

DHG sees profits rise

The Hau Giang Pharmaceutical Joint Stock Company (DHG) is expected to attain post-tax profit of VND705 billion in 2018, up 10 per cent year-on-year, Bao Viet Securities Company (BVSC) forecasts.
Japanese drug company increases stake in DHG

Japanese drug company increases stake in DHG

Japan’s Taisho Pharmaceutical Co Ltd has successfully purchased 9.2 million shares of DHG Pharmaceutical Joint Stock Company, representing a 7.06 per cent stake.
Pharmaceutical companys profit up 6 per cent

Pharmaceutical company’s profit up 6 per cent

Hau Giang Pharmaceutical Joint Stock Company, one of the leading companies in the pharmaceutical cosmetics industry, recorded profit of VND190 billion (US$4.3 million) in the second quarter of this year, up 6 per cent on-year.
Taisho offers to purchase DHG shares

Taisho offers to purchase DHG shares

Japanese pharmaceutical firm Taisho has offered to buy more than 9.23 million shares of DHG Pharmaceutical JSC (DHG), 7.06 per cent of DHG’s total shares.
DHG Pharma lifts foreign ownership limit to 100 per cent

DHG Pharma lifts foreign ownership limit to 100 per cent

Hau Giang Pharmaceutical Joint Stock Company, DHG Pharma, has completed the procedures to lift the foreign ownership cap from its current rate of 49 per cent to 100 per cent, effectively abolishing the cap altogether.
VCSC downgrade local pharmacy firm

VCSC downgrade local pharmacy firm

The Viet Capital Securities Joint Stock Company (VCSC) has forecast a bleak outlook on sluggish sales and rising input costs for Hau Giang Pharmaceutical Joint Stock Company (DHG).